Home › Research › Health systems and care delivery
IMPROVING DEMENTIA CARE THROUGH DIGITAL CAREGIVER EMPOWERMENT: DURABLE CLAIMS‐BASED OUTCOMES DEMONSTRATED IN A PRAGMATIC REAL‐WORLD TRIAL
Dirk G. Soenksen, Nathan L. Kleinman. Alzheimer s & Dementia, 2022-12-01
Topic: Risk, prevention and care in population studies
Abstract Objective The Ceresti Digital Caregiver Empowerment Program (DCEP) was deployed to 164 family caregivers of Medicare Advantage patients with ADOD. The primary objective of this pragmatic trial was to demonstrate that increasing the knowledge, skills and confidence of family caregivers (e.g., spouses, adult children) via personalized education, proactive coaching and remote monitoring—delivered via an app on a dedicated tablet computer—reduces avoidable patient hospitalizations. Durability of claims‐based outcomes was also studied. Caregiver engagement, caregiver satisfaction and caregiver mental health were also tracked Methods Patients were included in the claims analysis if their caregiver was enrolled in the DCEP for at least 45 days. Patient outcomes were compared to outcomes from a 3:1 propensity matched comparison group, post‐index, from the DCEP start date to the end of claims. Comparison group members were matched to enrollees on demographics, pre‐index utilization and costs, and other factors, including the patient’s frailty index. The first 30‐days post‐index were deemed a “transition” period. The impact of the DCEP was determined by comparing the 6‐month pre‐index averages to outcomes from the 30‐day post‐index period using the “difference‐in‐differences” approach (Figure 1). The index date for program enrollees was their DCEP start date. For matched comparison group patients, the index date was the program start date of the enrollee to whom the comparison group member is matched. The DCEP was personalized for each caregiver/patient dyad using predictive models applied to claims data. Results ‐ Patient Outcomes Table 1 summarizes statistically significant (p‐values 45 days, and enrolled high utilizers enrolled > 45 days (PMPM = per member/patient per month). High utilizers are patients with at least one hospitalization or two ED visits in the prior 24 months. Results were durable through 9 months post‐index (Figure 3). Conclusions Empowering family caregivers of patients with ADOD in a personalized DCEP provides durable reductions in patient hospitalizations and medical costs.
Key findings
- Patient outcomes were compared to outcomes from a 3:1 propensity matched comparison group, post‐index, from the DCEP start date to the end of claims.
- Results ‐ Patient Outcomes Table 1 summarizes statistically significant (p‐values 45 days, and enrolled high utilizers enrolled > 45 days (PMPM = per member/patient per month).
- Results were durable through 9 months post‐index (Figure 3).
Why it matters
This pragmatic trial of a digital caregiver empowerment program for family caregivers of Medicare Advantage patients with Alzheimer's disease and related dementias reported reductions in avoidable patient hospitalizations that were durable through 9 months. It suggests that supporting caregivers through education, coaching, and remote monitoring may help reduce hospital use, though it does not test a treatment or cure for the disease itself.
Study details
- Evidence strengthLow
How this study scored 27/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on institution's track record, so that was left out: it earned 26 of the 97 points we could judge it on, which is 27 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2022 — within 6 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 6 year(s) since 2022 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Nathan L. Kleinman: h-index 24 (OpenAlex, whole career) |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multi-centre collaboration | 0 / 3 | OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 26 / 97 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 26 of the 97 points we could judge it on is 27 out of 100. |
| Total | 27 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
APA 7th
Soenksen, D. G., & Kleinman, N. L. (2022). IMPROVING DEMENTIA CARE THROUGH DIGITAL CAREGIVER EMPOWERMENT: DURABLE CLAIMS‐BASED OUTCOMES DEMONSTRATED IN A PRAGMATIC REAL‐WORLD TRIAL. Alzheimer s & Dementia. https://doi.org/10.1002/alz.066038
Vancouver
Soenksen DG, Kleinman NL. IMPROVING DEMENTIA CARE THROUGH DIGITAL CAREGIVER EMPOWERMENT: DURABLE CLAIMS‐BASED OUTCOMES DEMONSTRATED IN A PRAGMATIC REAL‐WORLD TRIAL. Alzheimer s & Dementia. 2022. doi:10.1002/alz.066038.
BibTeX
@article{soenksen2022-ed962362,
author = {Soenksen, Dirk G. and Kleinman, Nathan L.},
title = {{IMPROVING DEMENTIA CARE THROUGH DIGITAL CAREGIVER EMPOWERMENT: DURABLE CLAIMS‐BASED OUTCOMES DEMONSTRATED IN A PRAGMATIC REAL‐WORLD TRIAL}},
journal = {Alzheimer s \& Dementia},
year = {2022},
doi = {10.1002/alz.066038},
url = {https://doi.org/10.1002/alz.066038}
}
Related studies in Health systems and care delivery
Also tagged “care”
996 studies in the library carry the topic tag “care”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 996 tagged studies.